Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. BM-3103 ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.

Whereas both dosing regimens of abrocitinib were effective among patients with atopic dermatitis, continuous treatment with abrocitinib 200 mg was associated with greater efficacy rates than variable ...

The addition of microneedling to topical minoxidil for the treatment of women with androgenetic alopecia provides no ...